NCT01090960View on ClinicalTrials.gov

A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Solid Cancers

Interventions

DRUG

GDC-0068

Oral repeating dose

Trial Locations (2)

46010

Valencia

08035

Barcelona

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY